Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dimitris Karathanasis
Observed names:
D Karathanasis,
D. Karathanassis,
Dimitris K. Karathanasis,
Dimitris Karathanassis,
Karathanasis, Dimitris
Institutions:
National and Kapodistrian University of Athens,
Eginition Hospital
Observed institutions:
Exelixis (United States),
National and Kapodistrian University of Athens,
Eginition Hospital,
EXELISIS IKE (Greece)
ORCID:
0000-0001-8070-6043
Observed ORCID:
0000-0001-8070-6043
OpenAlex ID:
A5075704227
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
2022
·
Sylvia Raftopoulou
, Anna Rapti
, et al.
·
Frontiers in Neurology
·
26
PDF
Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
2022
·
Dimitris K. Karathanasis
, Anna Rapti
, et al.
·
Frontiers in Pharmacology
·
21
Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
2023
·
Aigli G. Vakrakou
, Nikolaos Paschalidis
, et al.
·
Frontiers in Immunology
·
10
PDF
Epstein-Barr virus reactivation is associated with altered immune cell profiles in peripheral blood and cerebrospinal fluid of treatment-naive multiple sclerosis patients
2025
·
Vasileios Gouzouasis
, Margaritis Tsifintaris
, et al.
·
Journal of Neuroimmunology
·
9
Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis
2025
·
Victoria Lim Falk
, Nicole Mueller-Wirth
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
8
HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?
2022
·
Aigli Vakrakou
, Theofanis Chatzistamatiou
, et al.
·
Multiple Sclerosis and Related Disorders
·
6
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis
2023
·
Maud Bagnoud
, Jana Remlinger
, et al.
·
CNS Neuroscience & Therapeutics
·
4
PDF
Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue?
2022
·
L. Diem
, M.E. Evangelopoulos
, et al.
·
Multiple Sclerosis and Related Disorders
·
4
PDF
The Heimann-Bielschowsky phenomenon after optic neuritis
2022
·
E Anagnostou
, D Karathanasis
, et al.
·
Multiple Sclerosis and Related Disorders
·
4
Association of LILRA3 gene variants with central nervous system demyelinating syndromes of autoimmune origin in patients with late disease onset
2026
·
Sylvia Raftopoulou
, Vassilis E. Papadopoulos
, et al.
·
Scientific Reports
PDF
Rebuttal letter to “The need for functional correlation in assessing peripheral and CNS immunity during EBV reactivation”
2026
·
Vasileios Gouzouasis
, Margaritis Tsifintaris
, et al.
·
Journal of Neuroimmunology
Differentiating central nervous system demyelinating disorders using Graph Attention Networks
2026
·
Stamatis Choudalakis
, Anna Rapti
, et al.
·
medRxiv
PDF
Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in Greece
2025
·
Alexandra Akrivaki
, Dimitrios Tzanetakos
, et al.
·
Multiple Sclerosis and Related Disorders
Comparative Immunoprofiling of Peripheral Blood and Cerebrospinal Fluid in a Hellenic Cohort of Multiple Sclerosis Patients
2024
·
Vasileios Gouzouasis
, Spyros Tastsoglou
, et al.
·
SSRN Electronic Journal
Project website and social media presence
2022
·
Pyrgakis, Kostas
, Karathanasis, Dimitris
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
15
Citation count:
92
H-index:
6
I10-index:
3
Year
Topic
Type